G5 reported lower-than-expected topline in Q1, while good cost control supported solid profitability and EBIT results close to our forecast. Looking forward, we have lowered our growth assumptions as revenue from new games looks to take longer time than we previously anticipated, however this is partly mitigated by lower opex assumptions.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

© Modular Finance, source Nordic Press Releases